{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T15:09:41Z","timestamp":1771600181389,"version":"3.50.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T00:00:00Z","timestamp":1769644800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:00:00Z","timestamp":1771545600000},"content-version":"vor","delay-in-days":22,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Imaging"],"DOI":"10.1186\/s12880-026-02192-8","type":"journal-article","created":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T18:16:51Z","timestamp":1769710611000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Multimodal deep learning using preoperative CT and ultrasound for recurrence risk prediction in high-grade serous ovarian carcinoma"],"prefix":"10.1186","volume":"26","author":[{"given":"Silin","family":"Nie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yumin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanan","family":"Duan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yulu","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danni","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aiping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huijun","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,29]]},"reference":[{"key":"2192_CR1","doi-asserted-by":"publisher","unstructured":"Ittner E, et al. Diagnostic and prognostic biomarkers associated with histotype in advanced epithelial ovarian cancer. Sci Rep. Oct 23 2025;15(1):37171. https:\/\/doi.org\/10.1038\/s41598-025-24938-0","DOI":"10.1038\/s41598-025-24938-0"},{"key":"2192_CR2","doi-asserted-by":"publisher","first-page":"287","DOI":"10.2147\/ijwh.S197604","volume":"11","author":"Z Momenimovahed","year":"2019","unstructured":"Momenimovahed Z, Tiznobaik A, Taheri S, Salehiniya H. Ovarian cancer in the world: epidemiology and risk factors. Int J Womens Health. 2019;11:287\u201399. https:\/\/doi.org\/10.2147\/ijwh.S197604.","journal-title":"Int J Womens Health"},{"key":"2192_CR3","doi-asserted-by":"crossref","unstructured":"Lisio M-A, Fu L, Goyeneche A, Gao ZH, Telleria C. High-grade serous ovarian cancer: basic sciences, clinical and therapeutic standpoints. Int J Mol Sci. 2019;20(4):952. https:\/\/www.mdpi.com\/1422-0067\/20\/4\/952","DOI":"10.3390\/ijms20040952"},{"key":"2192_CR4","doi-asserted-by":"publisher","unstructured":"O\u2019Malley DM, Krivak TC, Kabil N, Munley J, Moore KN. PARP inhibitors in ovarian cancer: a review. Target Oncol. 2023 Jul;18(4):471\u2013503. https:\/\/doi.org\/10.1007\/s11523-023-00970-w","DOI":"10.1007\/s11523-023-00970-w"},{"key":"2192_CR5","doi-asserted-by":"publisher","unstructured":"Ledermann JA, et al. ESGO-ESMO-ESP consensus conference recommendations on ovarian cancer: pathology and molecular biology and early, advanced and recurrent disease. Ann Oncol. 2024 Mar;35(3):248\u2013266. https:\/\/doi.org\/10.1016\/j.annonc.2023.11.015","DOI":"10.1016\/j.annonc.2023.11.015"},{"key":"2192_CR6","doi-asserted-by":"publisher","unstructured":"Tewari KS, et al. Final overall survival of a randomized trial of bevacizumab for primary treatment of ovarian Cancer. J Clin Oncol. Sep 10 2019;37:2317\u201328. https:\/\/doi.org\/10.1200\/jco.19.01009.","DOI":"10.1200\/jco.19.01009"},{"key":"2192_CR7","doi-asserted-by":"publisher","unstructured":"Garzon S, et al. Secondary and tertiary ovarian cancer recurrence: what is the best management? Gland Surg. 2020 Aug;9(4):1118\u20131129. https:\/\/doi.org\/10.21037\/gs-20-325","DOI":"10.21037\/gs-20-325"},{"key":"2192_CR8","doi-asserted-by":"publisher","unstructured":"Shah JB, et al. Analysis of matched primary and recurrent BRCA1\/2 mutation-associated tumors identifies recurrence-specific drivers. Nat Commun. 2022 Nov 7;13(1):6728. https:\/\/doi.org\/10.1038\/s41467-022-34523-y","DOI":"10.1038\/s41467-022-34523-y"},{"key":"2192_CR9","doi-asserted-by":"publisher","unstructured":"Luvero D, Milani A, Ledermann JA. Treatment options in recurrent ovarian cancer: latest evidence and clinical potential. Ther Adv Med Oncol. 2014 Sep;6(5):229\u2013239. https:\/\/doi.org\/10.1177\/1758834014544121","DOI":"10.1177\/1758834014544121"},{"key":"2192_CR10","doi-asserted-by":"publisher","unstructured":"Ushijima K. Treatment for recurrent ovarian cancer at first relapse. J Oncol. 2010;2010:497429. https:\/\/doi.org\/10.1155\/2010\/497429","DOI":"10.1155\/2010\/497429"},{"key":"2192_CR11","doi-asserted-by":"publisher","unstructured":"Nag S, et al. Pan-Asia adapted ESMO clinical practice guideline for the management of patients with newly diagnosed and relapsed epithelial ovarian cancer. ESMO Open. 2025 Jun;10(6):105125. https:\/\/doi.org\/10.1016\/j.esmoop.2025.105125.","DOI":"10.1016\/j.esmoop.2025.105125"},{"key":"2192_CR12","doi-asserted-by":"publisher","unstructured":"Giampaolino P, Foreste V, Della Corte L, Di Filippo C, Iorio G, Bifulco G. Role of biomarkers for early detection of ovarian cancer recurrence. Gland Surg. 2020 Aug;9(4):1102\u20131111. https:\/\/doi.org\/10.21037\/gs-20-544","DOI":"10.21037\/gs-20-544"},{"key":"2192_CR13","doi-asserted-by":"publisher","unstructured":"Du K, et al. An increase of serum CA-125 to two times of nadir level strongly predicts the image-identified relapse of serous ovarian cancer. Sci Rep. Jul 1 2024;14(1):14986. https:\/\/doi.org\/10.1038\/s41598-024-65760-4.","DOI":"10.1038\/s41598-024-65760-4"},{"key":"2192_CR14","doi-asserted-by":"publisher","unstructured":"Zhou SK, et al. A review of deep learning in medical imaging: imaging traits, technology trends, case studies with progress highlights, and future promises. Proc IEEE Inst Electr Electron Eng. 2021 May;109(5):820\u2013838. https:\/\/doi.org\/10.1109\/jproc.2021.3054390","DOI":"10.1109\/jproc.2021.3054390"},{"key":"2192_CR15","doi-asserted-by":"publisher","unstructured":"Ardila D, et al. End-to-end lung cancer screening with three-dimensional deep learning on low-dose chest computed tomography. Nat Med. 2019 Jun;25(6):954\u2013961. https:\/\/doi.org\/10.1038\/s41591-019-0447-x","DOI":"10.1038\/s41591-019-0447-x"},{"key":"2192_CR16","doi-asserted-by":"publisher","unstructured":"Osny A, Parmar C, Quackenbush J, Schwartz LH, Aerts H. Artificial intelligence in radiology. Nat Rev Cancer. 2018 Aug;18(8):500\u2013510. https:\/\/doi.org\/10.1038\/s41568-018-0016-5","DOI":"10.1038\/s41568-018-0016-5"},{"key":"2192_CR17","doi-asserted-by":"publisher","unstructured":"Bi WL, et al. Artificial intelligence in cancer imaging: clinical challenges and applications. CA Cancer J Clin. 2019 Mar;69(2):127\u2013157. https:\/\/doi.org\/10.3322\/caac.21552","DOI":"10.3322\/caac.21552"},{"key":"2192_CR18","doi-asserted-by":"publisher","unstructured":"Schouten D, et al. Navigating the landscape of multimodal AI in medicine: a scoping review on technical challenges and clinical applications. Med Image Anal. 2025 Oct;105:103621. https:\/\/doi.org\/10.1016\/j.media.2025.103621","DOI":"10.1016\/j.media.2025.103621"},{"key":"2192_CR19","doi-asserted-by":"publisher","unstructured":"Yang H, Yang M, Chen J, Yao G, Zou Q, Jia L. Multimodal deep learning approaches for precision oncology: a comprehensive review. Brief Bioinform. 2024 Nov 22;26(1). https:\/\/doi.org\/10.1093\/bib\/bbae699","DOI":"10.1093\/bib\/bbae699"},{"issue":"48","key":"2192_CR20","doi-asserted-by":"publisher","first-page":"e30","DOI":"10.5114\/pjr.2024.134817","volume":"89","author":"MH Sadeghi","year":"2024","unstructured":"Sadeghi MH, Sina S, Omidi H, Farshchitabrizi AH, Alavi M. Deep learning in ovarian cancer diagnosis: a comprehensive review of various imaging modalities. Pol J Radiol. 2024;89(48):e30\u2013e. https:\/\/doi.org\/10.5114\/pjr.2024.134817.","journal-title":"Pol J Radiol"},{"key":"2192_CR21","doi-asserted-by":"publisher","unstructured":"Rizzo S, et al. Ovarian cancer staging and follow-up: updated guidelines from the European Society of Urogenital Radiology female pelvic imaging working group. Eur Radiol. 2025 Jul;35(7):4029\u20134039. https:\/\/doi.org\/10.1007\/s00330-024-11300-7","DOI":"10.1007\/s00330-024-11300-7"},{"key":"2192_CR22","doi-asserted-by":"publisher","unstructured":"Sahdev A. CT in ovarian cancer staging: how to review and report with emphasis on abdominal and pelvic disease for surgical planning. Cancer Imaging. 2016 Aug 2;16(1):19. https:\/\/doi.org\/10.1186\/s40644-016-0076-2","DOI":"10.1186\/s40644-016-0076-2"},{"key":"2192_CR23","doi-asserted-by":"publisher","unstructured":"Tantawy HFA, Ebrahim SAM, Kamal MRA, Hassan RM. The diagnostic performance of ultrasound in the diagnosis of indeterminate adnexal masses based on the O-RADS US scoring system. Egypt J Radiol Nucl Med. 2024 Jan 8;55(1):11. https:\/\/doi.org\/10.1186\/s43055-024-01184-4","DOI":"10.1186\/s43055-024-01184-4"},{"key":"2192_CR24","doi-asserted-by":"publisher","unstructured":"Xie W, et al. Developing a deep learning model for predicting ovarian cancer in Ovarian-Adnexal Reporting and Data System Ultrasound (O-RADS US) Category 4 lesions: a multicenter study. J Cancer Res Clin Oncol. 2024 Jul 9;150(7):346. https:\/\/doi.org\/10.1007\/s00432-024-05872-6.","DOI":"10.1007\/s00432-024-05872-6"},{"key":"2192_CR25","doi-asserted-by":"publisher","unstructured":"Zheng Y, et al. Preoperative CT-based deep learning model for predicting overall survival in patients with high-grade serous ovarian cancer. Front Oncol. 2022;12:986089. https:\/\/doi.org\/10.3389\/fonc.2022.986089","DOI":"10.3389\/fonc.2022.986089"},{"key":"2192_CR26","doi-asserted-by":"publisher","unstructured":"Wang S, et al. Deep learning provides a new computed tomography-based prognostic biomarker for recurrence prediction in high-grade serous ovarian cancer. Radiother Oncol. 2019 Mar;132:171\u2013177. https:\/\/doi.org\/10.1016\/j.radonc.2018.10.019","DOI":"10.1016\/j.radonc.2018.10.019"},{"key":"2192_CR27","doi-asserted-by":"publisher","unstructured":"Su C, Miao K, Zhang L, Dong X. Deep learning based on ultrasound images to predict platinum resistance in patients with epithelial ovarian cancer. Biomed Eng Online. 2025 May 13;24(1):58. https:\/\/doi.org\/10.1186\/s12938-025-01391-8","DOI":"10.1186\/s12938-025-01391-8"},{"key":"2192_CR28","doi-asserted-by":"publisher","unstructured":"Sadeghi MH, et al. Longitudinal deep learning models for tracking disease progression in ovarian cancer using PET\/CT imaging and clinical reports. Phys Eng Sci Med. 2025 Nov 10. https:\/\/doi.org\/10.1007\/s13246-025-01669-0.","DOI":"10.1007\/s13246-025-01669-0"},{"key":"2192_CR29","doi-asserted-by":"publisher","first-page":"593292","DOI":"10.3389\/fonc.2020.593292","volume":"10","author":"L Zhang","year":"2020","unstructured":"Zhang L, et al. Deep learning predicts overall survival of patients with unresectable hepatocellular carcinoma treated by transarterial chemoembolization plus Sorafenib. Front Oncol. 2020;10:593292. https:\/\/doi.org\/10.3389\/fonc.2020.593292.","journal-title":"Front Oncol"},{"key":"2192_CR30","doi-asserted-by":"publisher","unstructured":"Mahootiha M, Qadir HA, Bergsland J, Balasingham I. Multimodal deep learning for personalized renal cell carcinoma prognosis: integrating CT imaging and clinical data. Comput Methods Programs Biomed. 2024 Feb;244:107978. https:\/\/doi.org\/10.1016\/j.cmpb.2023.107978.","DOI":"10.1016\/j.cmpb.2023.107978"},{"key":"2192_CR31","doi-asserted-by":"publisher","unstructured":"Asadi F, Rahimi M, Ramezanghorbani N, Almasi S. Comparing the effectiveness of artificial intelligence models in predicting ovarian cancer survival: a systematic review. Cancer Rep (Hoboken). 2025 Mar;8(3):e70138. https:\/\/doi.org\/10.1002\/cnr2.70138","DOI":"10.1002\/cnr2.70138"},{"key":"2192_CR32","doi-asserted-by":"publisher","unstructured":"Zhang Y, Liao Q, Ding L, Zhang J. Bridging 2D and 3D segmentation networks for computation-efficient volumetric medical image segmentation: an empirical study of 2.5D solutions. Comput Med Imaging Graph. 2022 Jul;99:102088. https:\/\/doi.org\/10.1016\/j.compmedimag.2022.102088.","DOI":"10.1016\/j.compmedimag.2022.102088"},{"key":"2192_CR33","doi-asserted-by":"publisher","unstructured":"Singh SP, Wang L, Gupta S, Goli H, Padmanabhan P, Guly\u00e1s B. 3D deep learning on medical images: a review. Sensors (Basel). 2020 Sep 7;20(18). https:\/\/doi.org\/10.3390\/s20185097","DOI":"10.3390\/s20185097"},{"key":"2192_CR34","doi-asserted-by":"publisher","unstructured":"Tajbakhsh N, Jeyaseelan L, Li Q, Chiang JN, Wu Z, Ding X. Embracing imperfect datasets: a review of deep learning solutions for medical image segmentation. Med Image Anal. 2020 Jul;63:101693. https:\/\/doi.org\/10.1016\/j.media.2020.101693.","DOI":"10.1016\/j.media.2020.101693"},{"key":"2192_CR35","doi-asserted-by":"publisher","unstructured":"Anastasi E, et al. Recent insight about HE4 role in ovarian cancer oncogenesis. Int J Mol Sci. 2023 Jun 22;24(13). https:\/\/doi.org\/10.3390\/ijms241310479.","DOI":"10.3390\/ijms241310479"},{"key":"2192_CR36","doi-asserted-by":"publisher","unstructured":"Bryant A, et al. Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery. Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. https:\/\/doi.org\/10.1002\/14651858.CD015048.pub2","DOI":"10.1002\/14651858.CD015048.pub2"},{"key":"2192_CR37","doi-asserted-by":"publisher","unstructured":"Eisenkop SM, Spirtos NM, Friedman RL, Lin WC, Pisani AL, Perticucci S. Relative influences of tumor volume before surgery and the cytoreductive outcome on survival for patients with advanced ovarian cancer: a prospective study, (in eng). Gynecol Oncol. Aug 2003;90(2):390\u20136. https:\/\/doi.org\/10.1016\/s0090-8258(03)00278-6.","DOI":"10.1016\/s0090-8258(03)00278-6"}],"container-title":["BMC Medical Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12880-026-02192-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-026-02192-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-026-02192-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T14:22:43Z","timestamp":1771597363000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12880-026-02192-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,29]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2192"],"URL":"https:\/\/doi.org\/10.1186\/s12880-026-02192-8","relation":{},"ISSN":["1471-2342"],"issn-type":[{"value":"1471-2342","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,29]]},"assertion":[{"value":"6 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective study was reviewed and approved by the Ethics Committees of the Affiliated Hospital of Qingdao University. Written informed consent was waived due to the retrospective nature of the study, and patient data confidentiality was strictly ensured. All methods were carried out in accordance with relevant guidelines and regulations, including the ethical principles of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"107"}}